Patents by Inventor Kenneth C. Olson

Kenneth C. Olson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CROSS-LINKED HYALURONIC ACID AND COLLAGEN AND USES THEREOF
    Publication number: 20140227361
    Abstract: The present invention discloses a cross-linked hyaluronic acid/collagen formulation which has improved composition for dermal filling and higher persistence than cross-linked collagen or HA alone. Also disclosed are methods for preparing cross-linked hyaluronic acid/collagen formulations and using such for augmenting soft tissues in mammals.
    Type: Application
    Filed: April 14, 2014
    Publication date: August 14, 2014
    Applicant: Allergan, Inc.
    Inventors: Jacqueline A. Schroeder, Gregory S. Dapper, Kenneth C. Olson
  • Crossed-linked hyaluronic acid and collagen and uses thereof
    Patent number: 8703118
    Abstract: The present invention discloses a cross-linked hyaluronic acid/collagen formulation which has improved composition for dermal filling and higher persistence than cross-linked collagen or HA alone. Also disclosed are methods for preparing cross-linked hyaluronic acid/collagen formulations and using such for augmenting soft tissues in mammals.
    Type: Grant
    Filed: March 8, 2012
    Date of Patent: April 22, 2014
    Assignee: Allergan, Inc.
    Inventors: Jacqueline A. Schroeder, Gregory S. Dapper, Kenneth C. Olson
  • Crossed-linked hyaluronic acid and collagen and uses thereof
    Patent number: 8697044
    Abstract: The present invention discloses a cross-linked hyaluronic acid/collagen formulation which has improved composition for dermal filling and higher persistence than cross-linked collagen or HA alone. Also disclosed are methods for preparing cross-linked hyaluronic acid/collagen formulations and using such for augmenting soft tissues in mammals.
    Type: Grant
    Filed: October 7, 2008
    Date of Patent: April 15, 2014
    Assignee: Allergan, Inc.
    Inventors: Jacqueline A. Schroeder, Gregory S. Dapper, Kenneth C. Olson
  • Packaged product
    Patent number: 8338375
    Abstract: The present invention discloses collagen cross-linked in a micro to non-fibrillar form and at a high concentration. The cross-linked collagen gel has improved volume stability or persistence than collagen cross-linked at a neutral pH. Also disclosed are methods for preparing the inventive cross-linked collagen and using such for augmenting soft tissues in mammals.
    Type: Grant
    Filed: December 29, 2009
    Date of Patent: December 25, 2012
    Assignee: Allergan, Inc.
    Inventors: Jacqueline Anne Schroeder, Gregory S. Dapper, Kenneth C. Olson
  • CROSSED-LINKED HYALURONIC ACID AND COLLAGEN AND USES THEREOF
    Publication number: 20120164098
    Abstract: The present invention discloses a cross-linked hyaluronic acid/collagen formulation which has improved composition for dermal filling and higher persistence than cross-linked collagen or HA alone. Also disclosed are methods for preparing cross-linked hyaluronic acid/collagen formulations and using such for augmenting soft tissues in mammals.
    Type: Application
    Filed: March 8, 2012
    Publication date: June 28, 2012
    Applicant: ALLERGAN, INC.
    Inventors: Jacqueline A. Schroeder, Gregory S. Dapper, Kenneth C. Olson
  • CROSS-LINKED COLLAGEN AND USES THEREOF
    Publication number: 20100099624
    Abstract: The present invention discloses collagen cross-linked in a micro to non-fibrillar form and at a high concentration. The cross-linked collagen gel has improved volume stability or persistence than collagen cross-linked at a neutral pH. Also disclosed are methods for preparing the inventive cross-linked collagen and using such for augmenting soft tissues in mammals.
    Type: Application
    Filed: December 29, 2009
    Publication date: April 22, 2010
    Applicant: ALLERGAN, INC.
    Inventors: Jacqueline A. Schroeder, Gregory S. Dapper, Kenneth C. Olson
  • Cross-Linked Collagen and Uses Thereof
    Publication number: 20100099623
    Abstract: The present invention discloses collagen cross-linked in a micro to non-fibrillar form and at a high concentration. The cross-linked collagen gel has improved volume stability or persistence than collagen cross-linked at a neutral pH. Also disclosed are methods for preparing the inventive cross-linked collagen and using such for augmenting soft tissues in mammals.
    Type: Application
    Filed: December 29, 2009
    Publication date: April 22, 2010
    Applicant: ALLERGAN, INC.
    Inventors: Jacqueline A. Schroeder, Gregory S. Dapper, Kenneth C. Olson
  • CROSSED-LINKED HYALURONIC ACID AND COLLAGEN AND USES THEREOF
    Publication number: 20090093755
    Abstract: The present invention discloses a cross-linked hyaluronic acid/collagen formulation which has improved composition for dermal filling and higher persistence than cross-linked collagen or HA alone. Also disclosed are methods for preparing cross-linked hyaluronic acid/collagen formulations and using such for augmenting soft tissues in mammals.
    Type: Application
    Filed: October 7, 2008
    Publication date: April 9, 2009
    Inventors: Jacqueline A. Schroeder, Gregory S. Dapper, Kenneth C. Olson
  • Cross-linked collagen and uses thereof
    Publication number: 20080293637
    Abstract: The present invention discloses collagen cross-linked in a micro to non-fibrillar form and at a high concentration. The cross-linked collagen gel has improved volume stability or persistence than collagen cross-linked at a neutral pH. Also disclosed are methods for preparing the inventive cross-linked collagen and using such for augmenting soft tissues in mammals.
    Type: Application
    Filed: May 22, 2008
    Publication date: November 27, 2008
    Inventors: Jacqueline Anne Schroeder, Gregory S. Dapper, Kenneth C. Olson
  • Periplasmic protein recovery
    Patent number: 4680262
    Abstract: Periplasmic proteins are recovered from transformed gram negative bacteria by a process comprising freezing and thawing the cells. Advantages are obtained by culturing the cells in phosphate-limiting media and by killing the cells prior to separation of periplasmic proteins.
    Type: Grant
    Filed: October 5, 1984
    Date of Patent: July 14, 1987
    Assignee: Genentech, Inc.
    Inventors: Barry R. Bochner, Kenneth C. Olson, Rong-Chang Pai
  • Purification and activity assurance of precipitated heterologous proteins
    Patent number: 4518526
    Abstract: A process for isolating and purifying a precipitated heterologous protein from a host cell culture, including treating the host cell culture with a buffered solution of ionic strength suitable to solubilize most of the host protein but in which refractile heterologous protein is substantially insoluble, and disrupting the cells to form a supernatant and an insoluble fraction; treating the insoluble fraction with a strongly denaturing solution to solubilize the refractile heterologous protein; and recovering renatured heterologous protein.
    Type: Grant
    Filed: June 1, 1984
    Date of Patent: May 21, 1985
    Assignee: Genentech, Inc.
    Inventor: Kenneth C. Olson
  • Purification and activity assurance of precipitated heterologous proteins
    Patent number: 4512922
    Abstract: A process for maintaining refractile proteins in solubilized form by replacing the strongly denaturing solution with a weakly denaturing solution.
    Type: Grant
    Filed: June 1, 1984
    Date of Patent: April 23, 1985
    Assignee: Genentech, Inc.
    Inventors: Andrew J. S. Jones, Kenneth C. Olson, Steven J. Shire
  • Purification and activity assurance of precipitated heterologous proteins
    Patent number: 4511503
    Abstract: A process for dissolving refractile proteins from their insoluble form by using a strongly denaturing solution.
    Type: Grant
    Filed: June 1, 1984
    Date of Patent: April 16, 1985
    Assignee: Genentech, Inc.
    Inventors: Kenneth C. Olson, Rong-Chang Pai